Mesalamine 1.2 g/1

Mesalamine 1.2 g delayed-release tablets are used to manage inflammatory bowel conditions. This medication helps reduce inflammation in the colon and rectum, promoting gut health.

Mesalamine 1.2 g delayed-release tablets are primarily used for the maintenance of remission in ulcerative colitis. This medication works by reducing inflammation in the colon and rectum, helping to manage symptoms and promote gut health. Mesalamine is often prescribed for long-term use to prevent flare-ups and maintain remission.

Common effects of mesalamine 1.2 g delayed-release tablets may include mild stomach discomfort, nausea, or headache. Some users may experience diarrhea or mild abdominal cramps. These effects are usually temporary and subside as the body adjusts to the medication.

Mesalamine 1.2 g delayed-release tablets should be taken as directed by a healthcare provider. It is important to follow the prescribed dosage and not to crush or chew the tablets, as this can affect their delayed-release mechanism. Store the medication at room temperature, away from moisture and heat.

Mesalamine may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other bowel preparations. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using mesalamine, as it can increase the risk of side effects.